In the last decades, the volume of sufferers referred for allogeneic hematopoietic mobile transplantation has dropped substantially,133 although the process really should be recommended to younger/in good shape individuals in whom BCR/BCL2 inhibitor remedy fails, especially in those with TP53Tak hanya game, Hokky juga mewanti wanti masyarakat untuk